Company Search:
Advanced Search
Sponsored Links
Zhejiang Huahai Pharmaceutical Company Snapshot
Zhejiang Huahai Pharmaceutical operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Huahai Pharmaceutical with three other companies in this sector in China: Tong Ren Tang Technologies Company Limited (2017 sales of 5.03 billion Chinese Renmimbi [US$742.62 million] of which 70% was The Company), China Medical System Holdings Limited (5.35 billion Chinese Renmimbi [US$790.45 million] of which 100% was Pharmaceutical Products), and Zhejiang Conba Pharmaceutical Co., Ltd. (5.29 billion Chinese Renmimbi [US$782.08 million] of which 96% was Manufacturing).

Sales Analysis. Zhejiang Huahai Pharmaceutical reported sales of 5.00 billion Chinese Renmimbi (US$739.20 million) for the year ending December of 2017. This represents an increase of 22.2% versus 2016, when the company's sales were 4.09 billion Chinese Renmimbi. Sales at Zhejiang Huahai Pharmaceutical have increased during each of the previous five years (and since 2012, sales have increased a total of 148%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 1,953.1% in 2017, from 12,478.64 Chinese Renmimbi to 256,205.16 Chinese Renmimbi. Zhejiang Huahai Pharmaceutical also saw significant increases in sales in Drug Sale (up 34.4% to 2.64 billion Chinese Renmimbi) and Technical Service (up 212.8% to 48.07 million Chinese Renmimbi) and Other Operating (up 70.3% to 20.29 million Chinese Renmimbi) . Not all segments of Zhejiang Huahai Pharmaceutical experienced an increase in sales in 2017: sales of Import and Export Trade fell 31.5% to 150.24 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhejiang Huahai Pharmaceutical
  Stock Performance Chart for Zhejiang Huahai Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 11.97
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 2.4%  
4 Weeks -16.5%   52 Weeks -46.0%  
Zhejiang Huahai Pharmaceutical Key Data:
  Ticker: 600521 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,002,002,717
(Year Ending Jan 2018).
Employees: 6,065
  Currency: Chinese Renmimbi Market Cap: 14,972,538,497
  Fiscal Yr Ends: December Shares Outstanding: 1,250,838,638
  Share Type: A Gu Closely Held Shares: 625,273,432
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.